12:57:27 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-30 Bokslutskommuniké 2024
2024-05-03 Kvartalsrapport 2024-Q3
2024-02-09 Kvartalsrapport 2024-Q2
2023-10-27 Kvartalsrapport 2024-Q1
2023-09-25 Ordinarie utdelning VSD B 0.00 SEK
2023-09-22 Årsstämma 2024
2023-08-31 Bokslutskommuniké 2023
2023-05-04 Kvartalsrapport 2023-Q3
2023-02-09 Kvartalsrapport 2023-Q2
2022-10-27 Kvartalsrapport 2023-Q1
2022-10-07 Ordinarie utdelning VSD B 0.00 SEK
2022-10-06 Årsstämma 2023
2022-08-30 Bokslutskommuniké 2022
2022-07-05 Extra Bolagsstämma 2022
2022-05-04 Kvartalsrapport 2022-Q3
2022-02-11 Kvartalsrapport 2022-Q2
2021-10-22 Kvartalsrapport 2022-Q1
2021-10-06 Ordinarie utdelning VSD B 0.00 SEK
2021-10-05 Årsstämma 2022
2021-08-30 Bokslutskommuniké 2021
2021-05-12 Kvartalsrapport 2021-Q3
2021-02-12 Kvartalsrapport 2021-Q2
2020-11-12 Kvartalsrapport 2021-Q1
2020-10-08 Ordinarie utdelning VSD B 0.00 SEK
2020-10-07 Årsstämma 2021
2020-08-31 Bokslutskommuniké 2020
2020-05-15 Kvartalsrapport 2020-Q3
2020-05-04 Extra Bolagsstämma 2020
2020-02-14 Kvartalsrapport 2020-Q2
2019-11-01 Kvartalsrapport 2020-Q1
2019-10-10 Ordinarie utdelning VSD B 0.00 SEK
2019-10-09 Årsstämma 2020
2019-08-30 Bokslutskommuniké 2019
2019-05-16 Kvartalsrapport 2019-Q3
2019-02-14 Kvartalsrapport 2019-Q2
2018-10-30 Kvartalsrapport 2019-Q1
2018-10-17 Ordinarie utdelning VSD B 0.00 SEK
2018-10-16 Årsstämma 2019
2018-08-31 Bokslutskommuniké 2018
2018-05-16 Kvartalsrapport 2018-Q3
2018-02-14 Kvartalsrapport 2018-Q2
2017-10-30 Kvartalsrapport 2018-Q1
2017-10-02 Ordinarie utdelning VSD B 0.00 SEK
2017-09-29 Årsstämma 2018
2017-08-30 Bokslutskommuniké 2017
2017-05-22 Kvartalsrapport 2017-Q3
2017-02-20 Kvartalsrapport 2017-Q2
2017-01-25 Extra Bolagsstämma 2017
2016-11-07 Kvartalsrapport 2017-Q1
2016-08-29 Ordinarie utdelning VSD B 0.00 SEK
2016-08-26 Bokslutskommuniké 2016
2016-05-26 Kvartalsrapport 2016-Q3
2016-02-25 Kvartalsrapport 2016-Q2
2015-11-26 Kvartalsrapport 2016-Q1
2015-08-27 Bokslutskommuniké 2015

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Vibrosense Dynamics är verksamt inom medicinteknik. Bolaget utvecklar produkter och tjänster för diagnostikstöd vid nervskador i händer och fötter. Produkterna mäter och kvantifierar förmågan att känna vibrationer i huden, och används av vårdgivare för att kunna anpassa behandlingen eller sätta in förebyggande åtgärder vid potentiella nervskador. Bolagets kunder består huvudsakligen av diabetesmottagningar, sjukhus, vårdcentraler och forskningsinstitut.
2023-02-21 09:14:44

The Diabetes Clinic Herz und Diabetescentrum Nordrhein-Westfalen (HDZ NRW) has purchased VibroSense Meter® II and Diabetic Foot Screening after completed evaluation.

The clinic has been evaluating VibroSense Meter® II and the application Diabetic Foot Screening with a stated goal of purchasing the instrument after the evaluation is completed, provided that the instrument meets defined requirements. The order value is 16 500 EUR including an annual recurring software license fee of 2000 EUR.

The diabetes clinic at HDZ NRW is a highly ranked clinic at the university hospital in Bochum in Germany. In recent years (2020 and 2022), the clinic has received the highly regarded award "5-Sterne-Auszeichnung" awarded by the institute "Bundesverband Klinischer Diabetes-Einrichtungen" (BKvD).

"The order from HDZ NRW is a major and important breakthrough for VibroSense. We have invested in building knowledge and establishing a thorough plan for the German market, and the purchase of our product is proof that we have taken a big step forward in Germany. With several ongoing discussions, with other interesting clinics, it means a lot that we now may deliver our first instrument to HDZ NRW. Our plan for Germany is firm and we feel both optimistic and strengthened for the future," says Hans Wallin, CEO of VibroSense Dynamics AB.

About Diabetes Herz und Diabetescentrum in NRW Bad Oeynhausen

The Heart and Diabetes Center North Rhine-Westphalia (HDZ NRW) is a university clinic at the Ruhr University in Bochum and a leading international center for the treatment of heart, circulatory and diabetes diseases. With 35,000 heart and diabetes patients per year, of which 14,500 are inpatients, HDZ NRW is one of the largest and most modern clinical centers of its kind in Europe. The diabetes clinic at HDZ NRW has around 2,000 diabetes patients with all types of diabetes and its complications who are treated at the clinic every year. In addition to the treatment of cardiovascular diseases as well as endocrinology and gastroenterology, the diabetes center specializes in the treatment of nerve damage and circulatory disorders, including the care of diabetic foot syndrome.

Contact

Hans Wallin, CEO VibroSense Dynamics AB

Tel: +46 40 88 026
Email: info@vibrosense.com

www.vibrosense.se

"The new Gold Standard for reliable
detection of nerve damage"

About VibroSense Dynamics AB (publ)

VibroSense Dynamics AB (publ) develops and sells medical technology products and services for diagnostic support for nerve damage in the hands and feet. The method involves measuring and quantifying the ability to feel vibrations at several frequencies. The company's customers are diabetes clinics, occupational health care, hospitals, health centers and researchers.

Our vision is that the company's products should be a standard instrument in all neurological examinations to detect early signs of changes in sensation so that patients and their caregivers can implement preventive measures that prevent, reduce or delay the onset of nerve damage in the hands and feet.